-
公开(公告)号:US12169177B2
公开(公告)日:2024-12-17
申请号:US17786742
申请日:2020-12-17
Applicant: AMGEN INC.
Inventor: Graham F. Milne , Dmitry Fradkin
Abstract: Assemblies (10), devices, and methods are described herein that allow an examiner to inspect a container (12) of liquid product (14) through a bottom wall (18) of the container using a line-of-sight diversion member (28, e.g. beam splitter, mirror or prism). In some forms, the assemblies described herein can be provided with mounts and connecting arms to couple the devices to inspection booths.
-
公开(公告)号:US20240400664A1
公开(公告)日:2024-12-05
申请号:US18514269
申请日:2023-11-20
Applicant: AMGEN INC. , UCB PAHRMA S.A.
Inventor: Martyn K. Robinson , Michael S. Ominsky , Xiaodong Li , Hua Zhu Ke
Abstract: The invention relates to the treatment of bone disorders. In particular, the invention provides an approach involving administration of a high initial dose or doses of an sclerostin antibody to bring about a rapid increase in bone formation, followed by administration of lowers doses of the antibody to give a sustained lower rate of bone formation after the initial burst of bone formation. The invention also provides an approach involving decreasing dosing frequency with such an antibody to control bone formation. The approaches may be used in particular in those subjects who would benefit most from such an initial rapid burst of bone formation. Examples of such subjects include subjects who have been recently diagnosed or are experiencing severe symptoms of the disorder, as well as those subjects who have been administered a different treatment for the bone disorder which is proving ineffective. The approaches may be used in combination with each other.
-
公开(公告)号:US20240382673A1
公开(公告)日:2024-11-21
申请号:US18642384
申请日:2024-04-22
Applicant: AMGEN INC.
Inventor: Adam B. McCullough , Erich Coiner , Alan D. Payne
IPC: A61M5/142
Abstract: An insertion mechanism for a drug delivery device including a trocar, a housing, and a manifold in fluid communication with a fluid pathway connector and movable relative to the housing between a first manifold position adjacent to a proximal end of the housing and a second manifold position adjacent to a distal end of the housing. A hub carrying the trocar or hollow delivery needle is removably connected to the manifold, the hub being movable relative to the housing between a first hub position adjacent to the proximal end of the housing and a second hub position adjacent to the distal end of the housing. A power source is configured to generate rotational motion. A motion conversion mechanism operatively connects the power source and the hub, and is configured to convert the rotational motion into linear motion of the hub.
-
公开(公告)号:US20240374720A1
公开(公告)日:2024-11-14
申请号:US17928561
申请日:2021-05-28
Applicant: Amgen Inc.
Inventor: Anna IP , Ketaki PATEL , Clea TALLEY , Michael J. TREUHEIT , Jun ZHANG
IPC: A61K39/395 , A61K47/12 , A61K47/18 , A61K47/26 , C07K16/18
Abstract: Antibody formulations and methods of making and using such formulations are provided herein. The formulation can be for intravenous administration. In some embodiments, the formulation is for subcutaneous administration. In some embodiments, the formulation comprises an anti-C5 antibody, such as eculizumab.
-
公开(公告)号:USD1050422S1
公开(公告)日:2024-11-05
申请号:US29912831
申请日:2023-09-25
Applicant: AMGEN INC.
Designer: David Lavmand Muller
-
公开(公告)号:US12136359B2
公开(公告)日:2024-11-05
申请号:US17916124
申请日:2021-03-30
Applicant: AMGEN INC.
Inventor: Diogo Ferreira
IPC: G09F3/02
Abstract: A carton closure label is provided. The carton closure includes a first layer having a first adhesion value and a perforated portion extending at least substantially across a dimension of the first layer. The carton closure also includes a second layer removably coupled with the first layer, the second layer having a second adhesion value that is less than the first adhesion value.
-
公开(公告)号:US12134652B2
公开(公告)日:2024-11-05
申请号:US17111453
申请日:2020-12-03
Applicant: AMGEN INC.
Inventor: Thomas C. Boone , David W. Brankow , Colin V. Gegg, Jr. , Shaw-Fen Sylvia Hu , Chadwick T. King , Hsieng Sen Lu , Licheng Shi , Cen Xu
Abstract: Antigen binding proteins that bind to human CGRP receptor (CGRP R) are provided. Nucleic acids encoding the antigen binding protein, vectors, and cells encoding the same are also provided. The antigen binding proteins can inhibit binding of CGRP R to CGRP, and are useful in a number of CGRP R related disorders, including the treatment and/or prevention of migraine headaches.
-
公开(公告)号:US20240360079A1
公开(公告)日:2024-10-31
申请号:US18291285
申请日:2022-08-17
Applicant: AMGEN INC.
Inventor: Adrian ORTIZ , Jaika DOERFLER , Karina R. VAIDA
IPC: C07C319/12 , C07C321/26 , C12P13/00
CPC classification number: C07C319/12 , C07C321/26 , C12P13/001
Abstract: The present invention relates to precious metal (Pd/Pt/Rh/Ru) free, preferably Pd free, processes for preparing a compound having formula (1) wherein: R1, R2, and X are as defined in the specification, or a salt thereof. Preferably, the compound is an iodo acrylate compound.
-
公开(公告)号:USD1049367S1
公开(公告)日:2024-10-29
申请号:US29909619
申请日:2023-08-08
Applicant: AMGEN INC.
Designer: Jakob Halkjaer Kvist , Joshua Jay Dudman
Abstract: FIG. 1 is a perspective view showing a new design for a handheld drug delivery device with its needle shield in an extended position;
FIG. 2 is a front view of the handheld drug delivery device of FIG. 1;
FIG. 3 is a rear view of the handheld drug delivery device of FIG. 1;
FIG. 4 is a right-side view of the handheld drug delivery device of FIG. 1;
FIG. 5 is a left-side view of the handheld drug delivery device of FIG. 1;
FIG. 6 is a top view of the handheld drug delivery device of FIG. 1;
FIG. 7 is a bottom view of the handheld drug delivery device of FIG. 1;
FIG. 8 is a perspective view of the handheld drug delivery device of FIG. 1 with its needle shield in a retracted position;
FIG. 9 is a front view of the handheld drug delivery device of FIG. 8;
FIG. 10 is a rear view of the handheld drug delivery device of FIG. 8;
FIG. 11 is a right-side view of the handheld drug delivery device of FIG. 8;
FIG. 12 is a left-side view of the handheld drug delivery device of FIG. 8;
FIG. 13 is a top view of the handheld drug delivery device of FIG. 8;
FIG. 14 is a bottom view of the handheld drug delivery device of FIG. 8;
FIG. 15 is a perspective view showing a new design for a handheld drug delivery device with its needle shield in an extended position;
FIG. 16 is a front view of the handheld drug delivery device of FIG. 15;
FIG. 17 is a rear view of the handheld drug delivery device of FIG. 15;
FIG. 18 is a right-side view of the handheld drug delivery device of FIG. 15;
FIG. 19 is a left-side view of the handheld drug delivery device of FIG. 15;
FIG. 20 is a top view of the handheld drug delivery device of FIG. 15;
FIG. 21 is a bottom view of the handheld drug delivery device of FIG. 15;
FIG. 22 is a perspective view of the handheld drug delivery device of FIG. 15 with its needle shield in a retracted position;
FIG. 23 is a front view of the handheld drug delivery device of FIG. 22;
FIG. 24 is a rear view of the handheld drug delivery device of FIG. 22;
FIG. 25 is a right-side view of the handheld drug delivery device of FIG. 22;
FIG. 26 is a left-side view of the handheld drug delivery device of FIG. 22;
FIG. 27 is a top view of the handheld drug delivery device of FIG. 22; and,
FIG. 28 is a bottom view of the handheld drug delivery device of FIG. 22.
The broken lines are included for the purpose of illustrating portions of the design that form no part of the claimed design.-
公开(公告)号:US20240352112A1
公开(公告)日:2024-10-24
申请号:US18525130
申请日:2023-11-30
Applicant: AMGEN INC.
Inventor: Zhe Huang , Jennitte LeAnn Stevens , Greg Flynn , Szilan Fodor , Mark Daris
CPC classification number: C07K16/22 , A61K47/12 , A61K47/26 , A61K2039/505 , C07K2317/24
Abstract: The invention generally relates to anti-sclerostin antibodies having C-terminal modifications, and compositions comprising such antibodies.
-
-
-
-
-
-
-
-
-